201 related articles for article (PubMed ID: 12176894)
21. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.
Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N
Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761
[TBL] [Abstract][Full Text] [Related]
22. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
23. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
25. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
26. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D
J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491
[TBL] [Abstract][Full Text] [Related]
27. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553
[TBL] [Abstract][Full Text] [Related]
28. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells.
van Dommelen SL; Tabarias HA; Smyth MJ; Degli-Esposti MA
J Virol; 2003 Feb; 77(3):1877-84. PubMed ID: 12525622
[TBL] [Abstract][Full Text] [Related]
29. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A
Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells.
Nakui M; Ohta A; Sekimoto M; Sato M; Iwakabe K; Yahata T; Kitamura H; Koda T; Kawano T; Makuuchi H; Taniguchi M; Nishimura T
Clin Exp Metastasis; 2000; 18(2):147-53. PubMed ID: 11235990
[TBL] [Abstract][Full Text] [Related]
31. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.
Duthie MS; Kahn SJ
Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622
[TBL] [Abstract][Full Text] [Related]
32. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.
Ota T; Takeda K; Akiba H; Hayakawa Y; Ogasawara K; Ikarashi Y; Miyake S; Wakasugi H; Yamamura T; Kronenberg M; Raulet DH; Kinoshita K; Yagita H; Smyth MJ; Okumura K
Blood; 2005 Jul; 106(1):184-92. PubMed ID: 15746081
[TBL] [Abstract][Full Text] [Related]
34. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
[TBL] [Abstract][Full Text] [Related]
35. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
[TBL] [Abstract][Full Text] [Related]
36. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
Biburger M; Tiegs G
J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
[TBL] [Abstract][Full Text] [Related]
37. Natural killer T cell activation increases iNOS
Paul S; Chhatar S; Mishra A; Lal G
J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
[TBL] [Abstract][Full Text] [Related]
38. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.
Sainz V; Moura LIF; Peres C; Matos AI; Viana AS; Wagner AM; Vela Ramirez JE; S Barata T; Gaspar M; Brocchini S; Zloh M; Peppas NA; Satchi-Fainaro R; F Florindo H
Acta Biomater; 2018 Aug; 76():193-207. PubMed ID: 29940370
[TBL] [Abstract][Full Text] [Related]
39. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.
Schmieg J; Yang G; Franck RW; Tsuji M
J Exp Med; 2003 Dec; 198(11):1631-41. PubMed ID: 14657217
[TBL] [Abstract][Full Text] [Related]
40. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
